vor biopharma stock forecast

The average price target is 2275. 1 day and price target of 511 USD.


Vor Biopharma Inc Vor Stock Price Quote News Stock Analysis

Vor Biopharma Inc.

. MSFT 23850 041 AMD 5792 -007 AMZN 11636 226 AAPL 14375 094 NFLX 24086 -173 NVDA 11967 066 SQQQ 5659 -243. VOR stock forecast and price target Find the latest Vor Biopharma Inc. Vor Biopharma stock indicated to open around 36 or double the 18 IPO price Feb.

Is 278 for 2027 Jul. ET by Tomi Kilgore Vor Biopharma prices upsized IPO at the top of the expected. VOR one year forecast.

Is 353 and for 2031 Jul. VOR IEX Real-Time Price USD 391 015 385 Oct 12 2022 400 PM EDT - Market closed. Vor Biopharma Inc.

VOR share price prediction for 2022 2023 2024 2025 2026 and 2027. 165690 -710-043 View all reports Vor Biopharma Inc. Vor Bio is developing a proprietary platform built on Hematopoietic Stem Cell HSC biology genome engineering and CAR-T.

Vor Biopharma stock monthly and weekly forecasts. Vor Biopharma Stock Prediction. Vor Biopharma Inc.

On average analysts forecast that VORs EPS will be -231 for 2022 with the lowest EPS forecast at -247 and the. Vor Biopharma Stock Prediction. Vor Biopharma Stock Prediction.

VOR Vor Biopharmas current Earnings Per Share EPS is -217. VOR Stock Price Prediction 2275 43404 Upside Based on 5 Wall Street analysts offering 12 month price targets for Vor Biopharma in the last 3 months. Is 327 for 2026 Jul.

Vor Biopharma stock forecast 2022 - 2025 - 2030 with analysis. Our novel approach aims to transform blood cancer treatment. Is 512 for 2023 Jul.

Hot Stocks To Watch. Vor Biopharma stock stood at 603999996185303 on 2022-03-31. Find real-time VOR - Vor Biopharma Inc stock quotes company profile news and forecasts from CNN Business.

5 2021 at 1048 am. Vor Biopharma Inc stock price forecast for further price development up to 078 time horizon. VOR analyst stock forecast price target and.

According to latest technical analysis Vor Biopharma. Is a cell therapy company pioneering engineered hematopoietic stem cell therapies combined with targeted therapies for the treatment of cancer. Forecast for 2022 Aug.

Performance History Market Value Patterns. Vor Biopharma Stock Forecast - Naive Prediction. Vor Biopharma Stock Prediction.


Vor Biopharma Stock Targeted Therapies For Transplants Nasdaq Vor Seeking Alpha


Vor Biopharma Inc Shares Approach 52 Week Low Market Mover Nasdaq


Home Vor Bio


Marx Fertik Design Vor Biopharma


Vor Biopharma Stock Nasdaq Vor Quotes And News Summary Benzinga


Home Vor Bio


Vor Biopharma Inc Vor Stock Price Quote News Stock Analysis


424b4


Puretech Health Plc Half Year Report Business Wire


Vor Biopharma Inc Vor Stock Price Quote News Stock Analysis


1q21 Thirst For Preclinical Biotechs Unquenched Nature Biotechnology


Can Vor Biopharma Inc Vor Climb 298 To Reach The Level Wall Street Analysts Expect Nasdaq


Kymriah Blincyto And Besponsa To Drive Acute Lymphocytic Leukemia Market Growth


Puretech Founded Entity Vor Biopharma Closes Over 200m Initial Public Offering Business Wire


Vor Biopharma Stock Nasdaq Vor Quotes And News Summary Benzinga


Vor Biopharma Inc Vor Stock Price Quote News Stock Analysis


424b4


Home Vor Bio


Vor Biopharma Inc Vor Stock Price Quote News Stock Analysis

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel